# OnCo record paper-hensley-gemcitabine-docetaxel-leiomyosarcoma-jco-2002 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hensley-gemcitabine-docetaxel-leiomyosarcoma-jco-2002/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hensley-gemcitabine-docetaxel-leiomyosarcoma-jco-2002" ;
  schema:name "Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase 2 trial"@en ;
  schema:description "The combination of gemcitabine and docetaxel produced responses in more than half of patients with leiomyosarcoma, most of them uterine and many previously treated with doxorubicin, establishing a widely used second regimen for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-hensley-gemcitabine-docetaxel-leiomyosarcoma-jco-2002/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2002.11.050>, <https://pubmed.ncbi.nlm.nih.gov/12065559/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2002.11.050> ;
  schema:datePublished "2002"^^xsd:gYear ;
  schema:author "Hensley ML, Maki R, Venkatraman E, et al." ;
  onco:cancers <https://onco.cc/cancers/leiomyosarcoma/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:journals <https://onco.cc/journals/jco/> .
